Clinical Trial Update: CRE8 in All Comers Patients [NA]

View source ↗

Summary

The CRE8 study has completed enrollment for an all-comers trial of angioplasty in native coronary arteries with de novo lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Consecutive Subjects Who Are Suitable for a Coronary, Angioplasty of de Novo Lesion(s) in Native Coronary | NA | Status: COMPLETED